# sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.

> **NCT04766866** · NA · RECRUITING · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 9132 (estimated)

## Conditions studied

- Preeclampsia
- Intrauterine Growth Restriction
- Maternal Hypertension
- Neonatal Outcome
- Perinatal Death

## Interventions

- **DIAGNOSTIC_TEST:** sFlt1/PlGF screening in maternal blood at 35 to 36.6 weeks of gestation

## Key facts

- **NCT ID:** NCT04766866
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 9132 (ESTIMATED)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766866, "sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04766866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*